Literature DB >> 23966330

Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis.

Jot Hui Ooi1, Yunfei Li, Connie J Rogers, Margherita T Cantorna.   

Abstract

The active form of vitamin D [1,25-dihydroxycholecalciferol, 1,25(OH)2D3] and the vitamin D receptor (VDR) regulate susceptibility to experimental colitis. The effect of the bacterial microflora on the susceptibility of C57BL/6 mice to dextran sodium sulfate-induced colitis was determined. Mice that cannot produce 1,25(OH)2D3 [Cyp27b1 (Cyp) knockout (KO)], VDR KO as well as their wild-type littermates were used. Cyp KO and VDR KO mice had more bacteria from the Bacteroidetes and Proteobacteria phyla and fewer bacteria from the Firmicutes and Deferribacteres phyla in the feces compared with wild-type. In particular, there were more beneficial bacteria, including the Lactobacillaceae and Lachnospiraceae families, in feces from Cyp KO and VDR KO mice than in feces from wild-type. Helicobacteraceae family member numbers were elevated in Cyp KO compared with wild-type mice. Depletion of the gut bacterial flora using antibiotics protected mice from colitis. 1,25(OH)2D3 treatment (1.25 μg/100 g diet) of Cyp KO mice decreased colitis severity and reduced the numbers of Helicobacteraceae in the feces compared with the numbers in the feces of untreated Cyp KO mice. The mechanisms by which the dysbiosis occurs in VDR KO and Cyp KO mice included lower expression of E-cadherin on gut epithelial and immune cells and fewer tolerogenic dendritic cells that resulted in more gut inflammation in VDR and Cyp KO mice compared with wild-type mice. Increased host inflammation has been shown to provide pathogens with substrates to out-compete more beneficial bacterial species. Our data demonstrate that vitamin D regulates the gut microbiome and that 1,25(OH)2D3 or VDR deficiency results in dysbiosis, leading to greater susceptibility to injury in the gut.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23966330      PMCID: PMC3771816          DOI: 10.3945/jn.113.180794

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  44 in total

1.  A breathtaking feat: to compete with the gut microbiota, Salmonella drives its host to provide a respiratory electron acceptor.

Authors:  Sebastian E Winter; Andreas J Bäumler
Journal:  Gut Microbes       Date:  2011 Jan-Feb

Review 2.  Role of probiotic therapy in IBD.

Authors:  Kim Isaacs; Hans Herfarth
Journal:  Inflamm Bowel Dis       Date:  2008-11       Impact factor: 5.325

3.  Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis.

Authors:  Venu Lagishetty; Alexander V Misharin; Nancy Q Liu; Thomas S Lisse; Rene F Chun; Yi Ouyang; Sandra M McLachlan; John S Adams; Martin Hewison
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

Review 4.  Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

Authors:  Margherita T Cantorna; Brett D Mahon
Journal:  Exp Biol Med (Maywood)       Date:  2004-12

5.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

6.  Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.

Authors:  Juan Kong; Zhongyi Zhang; Mark W Musch; Gang Ning; Jun Sun; John Hart; Marc Bissonnette; Yan Chun Li
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-25       Impact factor: 4.052

7.  Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study.

Authors:  S P Jørgensen; J Agnholt; H Glerup; S Lyhne; G E Villadsen; C L Hvas; L E Bartels; J Kelsen; L A Christensen; J F Dahlerup
Journal:  Aliment Pharmacol Ther       Date:  2010-05-11       Impact factor: 8.171

8.  1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism.

Authors:  Hannelie Korf; Mathias Wenes; Benoit Stijlemans; Tatiana Takiishi; Sofie Robert; Michela Miani; Decio L Eizirik; Conny Gysemans; Chantal Mathieu
Journal:  Immunobiology       Date:  2012-08-01       Impact factor: 3.144

9.  Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.

Authors:  Monica Froicu; Margherita T Cantorna
Journal:  BMC Immunol       Date:  2007-03-30       Impact factor: 3.615

10.  Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

Authors:  H G Pálmer; J M González-Sancho; J Espada; M T Berciano; I Puig; J Baulida; M Quintanilla; A Cano; A G de Herreros; M Lafarga; A Muñoz
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  131 in total

1.  Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.

Authors:  Prasant K Jena; Lili Sheng; Hui-Xin Liu; Karen M Kalanetra; Annie Mirsoian; William J Murphy; Samuel W French; Viswanathan V Krishnan; David A Mills; Yu-Jui Yvonne Wan
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

2.  Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD.

Authors:  Yilan Zeng; Mei Luo; Liwei Pan; Yuan Chen; Siqi Guo; Dongxia Luo; Li Zhu; Yong Liu; Lisha Pan; Siya Xu; Ruofei Zhang; Chunyan Zhang; Pengfei Wu; Liangpeng Ge; Mazen Noureddin; Stephen J Pandol; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

Review 3.  The intestinal microbiome and skeletal fitness: Connecting bugs and bones.

Authors:  Julia F Charles; Joerg Ermann; Antonios O Aliprantis
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

Review 4.  Current evidence for vitamin D in intestinal function and disease.

Authors:  Mohammadhossein Hassanshahi; Paul H Anderson; Cyan L Sylvester; Andrea M Stringer
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-31

Review 5.  Metabolites: deciphering the molecular language between DCs and their environment.

Authors:  Lucía Minarrieta; Peyman Ghorbani; Tim Sparwasser; Luciana Berod
Journal:  Semin Immunopathol       Date:  2016-12-05       Impact factor: 9.623

Review 6.  Role of vitamin D on gut microbiota in cystic fibrosis.

Authors:  Mansi Kanhere; Benoit Chassaing; Andrew T Gewirtz; Vin Tangpricha
Journal:  J Steroid Biochem Mol Biol       Date:  2016-11-03       Impact factor: 4.292

Review 7.  Pediatric Obesity-Related Asthma: The Role of Metabolic Dysregulation.

Authors:  Nandini Vijayakanthi; John M Greally; Deepa Rastogi
Journal:  Pediatrics       Date:  2016-04-08       Impact factor: 7.124

8.  Diarrheal Mechanisms and the Role of Intestinal Barrier Dysfunction in Campylobacter Infections.

Authors:  Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

9.  Maternal vitamin D beneficially programs metabolic, gut and bone health of mouse male offspring in an obesogenic environment.

Authors:  C R Villa; J Chen; B Wen; S M Sacco; A Taibi; W E Ward; E M Comelli
Journal:  Int J Obes (Lond)       Date:  2016-10-04       Impact factor: 5.095

Review 10.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.